Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | compounds already reach it: amg-108, medi-8968, anakinra | 0.81 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 0 stopped | 1.00 |
| literature PubMed | 10 Parkinson's papers of 1,384 | 0.69 |
| pathways Reactome | 3 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 7335
Sealed predictions
- IL1R1 in dopamine neurons, braak+0.02 (p 0.964) → -0.12 (p 0.767)receipt 7343
Swarm cases
receipt 7343: IL1R1 in dopamine neurons, braak
- power
- full sample +0.01 (p 0.976, n 18), 95% CI -0.46 to +0.47. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.04 (p 0.861, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.01 (p 0.983, n 18). could be the mix.
- skeptic
- leave-one-out range -0.11 to +0.13, sign flips 5; without severely affected donors +0.01 (p 0.976, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IL1R1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts